An open label, randomized Phase II study of BI 754091 alone or in combination with BI 836880 in patients with chemotherapy resistant, unresectable, metastatic squamous cell carcinoma of the anal cancer

Project: Research

Project Details

StatusActive
Effective start/end date21/08/2020/08/25

Keywords

  • clinical trial
  • anal cancer
  • treatment efficacy